Stewart Landau, MD
Urology · American Fork, UTNPI 1174559728
Payments from drug & device makers
Across 459 payments — averaging $59.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$17K
- Sanofi$2K
- Astellas Pharma US Inc$1K
- Pfizer$1K
- AstraZeneca$1K
- Johnson & Johnson$966
- plus $4K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 90 | $16,938 |
| Sanofi | 2 | $1,832 |
| Astellas Pharma US Inc | 59 | $1,381 |
| Pfizer | 64 | $1,165 |
| AstraZeneca | 12 | $1,146 |
| Johnson & Johnson | 25 | $966 |
| Sumitomo Pharma America, Inc. | 47 | $669 |
| Bayer | 18 | $510 |
| Accord Healthcare, Inc. | 12 | $335 |
| Amgen | 13 | $321 |
| AbbVie(2 entities) | 18 | $296 |
| Myovant Sciences Inc. | 21 | $248 |
| Urovant Sciences Inc | 8 | $161 |
| Procept Biorobotics Corporation | 2 | $141 |
| Endo Pharmaceuticals Inc. | 9 | $140 |
| Myriad Genetic Laboratories, Inc. | 8 | $119 |
| Travere Therapeutics, Inc. | 8 | $111 |
| Antares Pharma, Inc. | 7 | $102 |
| Telix Pharmaceuticals | 2 | $73 |
| Merck | 4 | $73 |
| Foundation Medicine, Inc. | 4 | $59 |
| Janssen Scientific Affairs, LLC | 2 | $58 |
| Urogen Pharma, Inc. | 3 | $56 |
| Sun Pharmaceutical Industries Inc. | 2 | $48 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $43 |
| Coloplast | 1 | $42 |
| Blue Earth Diagnostics | 2 | $41 |
| Endo USA, Inc. | 2 | $34 |
| Tolmar, Inc. | 2 | $33 |
| Novo Nordisk | 1 | $30 |
| Tolmar Pharmaceuticals, Inc. | 2 | $26 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Boston Scientific | 1 | $25 |
| Civco Medical Instruments | 1 | $24 |
| Novartis | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $10 |
How this compares
$27,349 in reported general payments places this provider in the 80th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in American Fork
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Sean HendersonAmerican Fork$21K
- Daniel CahoonAmerican Fork$18K
- Landon TrostOrem$5.2M
- Steven GangeSlc$1.6M
- Jay PageSandy$507K
- William BrantSalt Lake City$290K
- Christopher DechetSalt Lake City$142K
- David AdamsLogan$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.